🇺🇸 FDA
Patent

US 7842701

Pyrazoloquinolone derivative and use thereof

granted A61PA61P1/02A61P1/04

Quick answer

US patent 7842701 (Pyrazoloquinolone derivative and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18